Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Dry Eye Clinical Trials

100 recruiting trials for Dry Eye. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06448468

Analysis of Ocular Surface Microbiota in Dry Eye Patients After Femtosecond Laser-assisted In-situ Keratomileusis...

By using 16S rRNA sequencing technology to analyze the changes in ocular surface microbiota before and after surgery, as well as the impact of changes in ocular surface microbiota...

Sponsor: Second Affiliated Hospital of Nanchang UniversityEnrolling: 2001 location
RECRUITINGPhase 4NCT07277257

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs...

Sponsor: Center For SightEnrolling: 351 location
RECRUITINGPhase 1 / Phase 2NCT04339764

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy...

Background: Age-related macular degeneration is a common eye disease in people over 50. The "dry" form of the disease can worsen into geographic atrophy, causing blind spots....

Sponsor: National Eye Institute (NEI)Enrolling: 202 locations
RECRUITINGPhase 1 / Phase 2NCT07298811

Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the...

Evaluate the efficacy and safety of ocular surface microbiota transplantation as an adjunctive therapy for dry eye, and explore its impact on the structure of the ocular surface...

Sponsor: Second Affiliated Hospital of Nanchang UniversityEnrolling: 401 location
RECRUITINGPhase 2NCT07118254

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML...

An 84-day, prospective, randomized (1:1) vehicle controlled, double-masked pre-market, crossover study. Subjects with moderate to severe oGVHD related Dry Eye Disease Each subject...

Sponsor: Lubris Bio Pty LtdEnrolling: 153 locations
RECRUITINGPhase 4NCT07153276

TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE

Sjögren's disease (SjD) is a chronic, immune-mediated, systemic inflammatory disease characterized mainly by involvement of the salivary and lacrimal glands, causing symptoms of...

Sponsor: University of Sao Paulo General HospitalEnrolling: 601 location
RECRUITINGNCT02327884

Characterization of Diseases With Salivary Gland Involvement

Background: \- Salivary glands in and around the mouth and throat make saliva. Salivary gland disorders can affect a person s quality of life. Studying people who have a disease...

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)Enrolling: 11501 location
RECRUITINGNCT07238699

An Evaluation of the Safety and Tolerability of Ocular Lubricants

The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye disease.

Sponsor: Alcon ResearchEnrolling: 1484 locations
RECRUITINGPhase 1NCT07236801

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 182 locations
RECRUITINGNCT06379646

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

An exploratory clinical study of the safety and efficacy of YTS109 cell injection in subjects with recurrent/refractory autoimmune disease

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 61 location
RECRUITINGNCT07255859

CRYSTALSIGHT Cohort 2.0

Age-Macular Degeneration (AMD) is a common eye condition and a leading cause of vision loss among people age 50 and older. It causes damage to the macula, a small area near the...

Sponsor: Tan Tock Seng HospitalEnrolling: 601 location
RECRUITINGNCT07412860

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and...

The goal of this clinical investigation plan is to evaluate the performance, tolerability, safety, and compliance of an ophthalmic solution containing an ancillary medicinal...

Sponsor: FB Vision S.p.AEnrolling: 742 locations
RECRUITINGPhase 1NCT07371468

A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

This is a 2-part study of GSK5926371 in participants with autoimmune rheumatic diseases (ARD). In part 1, participants will receive different doses of GSK5926371 to find a...

Sponsor: GlaxoSmithKlineEnrolling: 543 locations
RECRUITINGPhase 2NCT07118241

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML...

rhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in subjects with Sjögren's related...

Sponsor: Lubris Bio Pty LtdEnrolling: 806 locations
RECRUITINGNCT06298890

The Pattern of Dry Eye Disease After Cataract Surgery

This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with...

Sponsor: Lithuanian University of Health SciencesEnrolling: 1001 location
RECRUITINGNCT06339957

Rheumatology Diet Study

This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on...

Sponsor: University of Central FloridaEnrolling: 5001 location
RECRUITINGNCT07180537

Creating Health Course Study for People With Rheumatological Conditions

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological...

Sponsor: Terry L. WahlsEnrolling: 2001 location
RECRUITINGPhase 2NCT07281456

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

Background: Sjogren disease is an autoimmune disease - that is, a disease that causes the body's immune system to attack its own organs and tissues. Sjogren disease can affect...

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)Enrolling: 601 location
RECRUITINGPhase 4NCT07191847

Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops

Dry Eye Disease (DED) is a multifactorial condition that affects the ocular surface, leading to discomfort, tear film instability, and potential visual disturbances. Its global...

Sponsor: Ace Cells Lab LimitedEnrolling: 3001 location
RECRUITINGNCT06842316

Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases

Cannabis, in addition to its psychotropic properties, could have anti-inflammatory and immunomodulatory effects. Phytocannabinoids (pCBs) are a group of molecules naturally...

Sponsor: Centre Hospitalier Régional d'OrléansEnrolling: 1001 location
RECRUITINGPhase 2NCT07128628

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice...

Sponsor: Bausch & Lomb IncorporatedEnrolling: 42320 locations
RECRUITINGNCT07155057

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Sponsor: Vance Thompson VisionEnrolling: 601 location
RECRUITINGNCT03921931

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT)...

Sponsor: Medical University of ViennaEnrolling: 351 location
RECRUITINGNCT06163989

Protecting the Eyes of Gamers With Lubricating Eyedrops

The excessive use of screens particularly amongst digital gamers can adversely impact the health of the surface of the eyes with symptoms and signs of surface damage. While...

Sponsor: Aston UniversityEnrolling: 281 location
RECRUITINGNCT05465252

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

This randomized, double-blind, placebo-controlled study aims to evaluate the effect of krill oil supplementation in patients with dry age-related macular degeneration (AMD)....

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling: 241 location
RECRUITINGNCT04697095

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

Age-related macular degeneration (AMD) affects 2 million people in France and is the main cause of irreversible blindness in France. All patients initially have an early form of...

Sponsor: Hospices Civils de LyonEnrolling: 802 locations
RECRUITINGPhase 1 / Phase 2NCT07062523

Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT

Sjögren's syndrome (SS) is a chronic autoimmune disease primarily affecting the salivary and lacrimal glands, leading to symptoms of dryness. Assessing the inflammatory activity...

Sponsor: Peking Union Medical College HospitalEnrolling: 601 location
RECRUITINGNCT07144137

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

This is a non-interventional, observational study to provide insights into the short-term progression of GA secondary to AMD in participants aged ≥55 years. This is a...

Sponsor: Complement TherapeuticsEnrolling: 757 locations
RECRUITINGNCT03003572

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

Primary Sjögren's syndrome (pSS) can affect various organs, sometimes leads to life-threatening conditions and is always responsible for a decreased quality of life. Its evolution...

Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 1858 locations
RECRUITINGNCT06771427

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic...

Sponsor: Taipei Veterans General Hospital, TaiwanEnrolling: 2201 location
RECRUITINGNCT05644795

Wheat-free Diet in the Treatment of Sjogren's Syndrome

Recent data show that some foods can increase intestinal mucosa permeability and immune activation of subjects with gastrointestinal (GI) symptoms. Wheat seems the most frequent...

Sponsor: University of PalermoEnrolling: 303 locations
RECRUITINGPhase 3NCT06291194

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56 5%) compared to control drug(vehicle) in Patients with Dry Eye Disease.

Sponsor: AJU Pharm Co., Ltd.Enrolling: 3961 location
RECRUITINGPhase 4NCT07451184

Comparison of Ocular Lubricants in People With Symptoms of Dry Eye

Ocular dryness and discomfort are symptoms commonly associated with dry eye. Lubricating eye drops, also called artificial tears, are often used to moisten the eye and provide...

Sponsor: University of WaterlooEnrolling: 1001 location
RECRUITINGPhase 4NCT06886373

Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for...

Compare the corneal astigmatism data before and after the use of Systane COMPLETE to evaluate its impact on predicting changes in postoperative residual astigmatism, as well as...

Sponsor: National Taiwan University HospitalEnrolling: 1401 location
RECRUITINGNCT07298291

Ocular Proteomics Testing In Chronic Atrophy

Study to evaluate the safety of routine diagnostic anterior chamber paracentesis (ACP) for proteomic profiling in patients with geographic atrophy (GA)

Sponsor: ClinOmicsAIEnrolling: 501 location
RECRUITINGNCT07295691

Autologous Serum Eye Drops in Dry Eye Syndrome

This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to...

Sponsor: The General Authority for Teaching Hospitals and InstitutesEnrolling: 701 location
RECRUITINGNCT06046118

Photobiomodulation in Dry Age Related Macular Degeneration

The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The...

Sponsor: Azienda Ospedaliera Universitaria Mater Domini, CatanzaroEnrolling: 1807 locations
RECRUITINGPhase 3NCT06392438

Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users

In this study, two treatments typically used for dry eye disease will be tried for contact lens users to see if their symptoms when they use their contact lenses get better....

Sponsor: Université de SherbrookeEnrolling: 441 location
RECRUITINGNCT04946721

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Sponsor: University of Maryland, BaltimoreEnrolling: 1501 location
RECRUITINGPhase 4NCT07025811

A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED)...

Sponsor: Hoffmann-La RocheEnrolling: 3505 locations
RECRUITINGPhase 3NCT06766357

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

This study is a multicenter, randomized, double-blind, placebo-controlled, superiority design Phase III clinical trial. The primary objective is to evaluate the efficacy and...

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Enrolling: 3601 location
RECRUITINGNCT06513000

Dryness Difference Between Before and After Phacoemulsification

The aim of this study is to compare tear film and tear film secretion before and after phacoemulsificaton cataract surgery

Sponsor: Sohag UniversityEnrolling: 1001 location
RECRUITINGNCT06841471

Role of Corneal Nerves in Dry Eye Disease

This study aims to determine whether corneal nerve function and morphology are affected by tear film instability and ocular surface homeostasis loss. Additionally, it seeks to...

Sponsor: Daniela NoschEnrolling: 1401 location
RECRUITINGNCT07363824

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

This study aims to see if the amount of iron in tears is linked to how severe dry eye disease is. We hope this can lead to a new way to help diagnose and understand dry eye. This...

Sponsor: Shanghai Changzheng HospitalEnrolling: 521 location
RECRUITINGPhase 2NCT05113004

New Clinical End-points in Patients With Primary Sjögren's Syndrome

There are no approved treatments for pSS and the clinical endpoints currently used in clinical trials are inadequate to capture all aspects of the disease that should be evaluated...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 3007 locations
RECRUITINGPhase 1NCT06392711

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

The goal of this clinical trial is to evaluate the safety and tolerability of injecting certain cells produced in bone marrow called mesenchymal stromal cells (MSCs) into salivary...

Sponsor: University of Wisconsin, MadisonEnrolling: 361 location
RECRUITINGPhase 1NCT06263998

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy...

Sponsor: Huons Co., Ltd.Enrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT06805448

Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's...

Living with dry mouth significantly impacts daily life, causing constant discomfort. It makes it harder to talk, eat solid food (increasing the risk of malnutrition), swallow, and...

Sponsor: Rigshospitalet, DenmarkEnrolling: 401 location
RECRUITINGPhase 4NCT07463950

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free...

Dry eye disease (DED) is a common, multifactorial ocular surface condition with increasing worldwide prevalence. DED induces a significant burden to the patients. Inflammatory...

Sponsor: Medical University of ViennaEnrolling: 251 location
RECRUITINGPhase 4NCT06017362

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors,...

Sponsor: Barbara Burgos BlascoEnrolling: 1001 location

Showing 50 of 100 trials.Search all Dry Eye trials

Frequently Asked Questions

There are currently 100 clinical trials for Dry Eye, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Dry Eye, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 3 Phase 3 trials for Dry Eye, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.